Shengping Shen
Shanghai, 200030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
MAT1A activation of glycolysis to promote NSCLC progression depends on stabilizing CCND1.
Journal: Cell death & disease
Published: November 29, 2023
Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer.
Journal: Experimental hematology & oncology
Published: October 29, 2023
ASO Video Abstract: Neoadjuvant Chemo-Immunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable NSCLC.
Journal: Annals of surgical oncology
Published: August 24, 2023
ASO Author Reflections: Immune Microenvironment Indicators in Neoadjuvant Chemo-Immunotherapy.
Journal: Annals of surgical oncology
Published: July 28, 2023
Retraction Note: SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 15, 2023
Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer.
Journal: Annals of surgical oncology
Published: November 22, 2022
Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients.
Journal: Journal of hematology & oncology
Published: April 03, 2022
The relationship between different subtypes of KRAS and PD-L1 & tumor mutation burden (TMB) based on next-generation sequencing (NGS) detection in Chinese lung cancer patients.
Journal: Translational lung cancer research
Published: December 17, 2021
Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 16, 2019
Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma.
Journal: Thoracic cancer
Published: October 29, 2018
Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study.
Journal: Cancer management and research
Published: September 30, 2018
SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 26, 2018
Last Updated: 09/26/2026